News and Insights
The latest news and insights from Genoa Healthcare.
- Behavioral Health
- Clinical Insights
- Treatment
Fact or fiction: 6 things to know about medication-assisted treatment
1.Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD). (2018, December 18). NIH. 2. Medications for substance use disorders (2023, February 21). SAMHSA. 3. Medications for substance use disorders (2023, February...
- Mar 1st, 2023
- Behavioral Health
- Genoa in the News
- Treatment
Pharmacists can start patients on road to recovery from opioid use disorder, study shows
A study in the New England Journal of Medicine showed that pharmacies can offer a safe and accessible treatment starting point for patients with opioid use disorder and keep them...
- Jan 11th, 2023
- Behavioral Health
- Clinical Insights
- Treatment
Webinar: Medication-assisted Treatment: Trends and Outcomes
For consumers living with opioid use disorder (OUD), medication-assisted treatment (MAT) has become the gold standard of treatment. In a new webinar, Genoa Healthcare Director of Operations Megan Garrity, PharmD,...
- Dec 20th, 2022
- Behavioral Health
- Clinical Insights
Webinar: Improving outcomes during transitions of care
In a new webinar, Genoa Directors of Operations Joseph Pellerito and Katie Lozano share how organizations are addressing risks associated with transitions of care through unique partnerships and programs to...
- Oct 5th, 2022
- Behavioral Health
- Clinical Insights
Fighting stigma around substance use disorder
Words matter when you provide care for people with substance use disorder (SUD), says Genoa pharmacist Shawn Zwilling. Zwilling’s pharmacy is located onsite at the St. Louis-based Assisted Recovery Centers...
- Sep 7th, 2022
- Behavioral Health
- Clinical Insights
- Treatment
New medication options in behavioral health
FDA Approves 14 New Medications The FDA has approved 14 new medication and treatment options for the behavioral health space to date in 2022. The new medication and treatment options...
- Jun 24th, 2022
- Behavioral Health
- Clinical Insights
- Treatment
Webinar: Long-Acting Injectable Antipsychotics in Practice
Treating Schizophrenia Long-acting injectable (LAI) antipsychotic formulations are being considered more often in the treatment of schizophrenia to promote medication adherence. Genoa Healthcare recently hosted a webinar providing an update...
- Dec 9th, 2021
- Behavioral Health
- Clinical Insights
- Treatment
Webinar: New Medication Options in Behavioral Health
Behavioral Health Drug Updates This year the Federal Drug Administration’s Center for Drug Evaluation and Research (CDER) approved a number of new drug therapies to treat behavioral health conditions, including...
- Oct 8th, 2021
- Behavioral Health
- People-first Pharmacy Care
Genoa Healthcare Expands Mental Health Training for Its Pharmacy Teams, Addressing Growing Need for Access to Behavioral Health Care
Investment in training will deepen pharmacy teams’ expertise and lead to a higher level of care Increase in Mental Health Training for Pharmacists RENTON, Wash. (August 11, 2021) – Recognizing...
- Aug 16th, 2021
- Behavioral Health
- Clinical Insights
- Treatment
Webinar: What Providers Need to Know: New Medication Options in Behavioral Health
Behavioral Drug Approvals in 2020 The FDA’s Center for Drug Evaluation and Research approved 53 new drugs in 2020 alone, including several novel treatments for schizophrenia and other behavioral health...
- Jul 6th, 2021